Common Contracts
3 similar null contracts by Acura Pharmaceuticals, Inc
SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC.Acura Pharmaceuticals, Inc • January 31st, 2006 • Pharmaceutical preparations • New York
This Note was issued by the Company pursuant to a certain Loan Agreement dated as of January , 2006 among the Company and certain lenders identified therein, including the Payee (together with the Schedules and Exhibits thereto, the “Loan Agreement”). The holders from time to time of the Notes issued under the Loan Agreement (including the Holder) are referred to hereinafter as the “Holders”. The Holder is entitled to the benefits of the Loan Agreement, including, without limitation, the rights upon the occurrence and during the continuance of an Event of Default and the benefits of security interests and guaranties referred to below. Reference is made to the Loan Agreement and the documents entered into pursuant thereto with respect to certain additional rights of the Holder and obligations of the Company and its Subsidiaries not expressly set forth herein. Capitalized terms used herein but not otherwise defined herein shall have the meaning ascribed thereto in the Loan Agreement. All
SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC.Acura Pharmaceuticals, Inc • November 10th, 2005 • Pharmaceutical preparations • New York
This Note was issued by the Company pursuant to a certain Loan Agreement dated as of November , 2005 among the Company and certain lenders identified therein, including the Payee (together with the Schedules and Exhibits thereto, the “Loan Agreement”). The holders from time to time of the Notes issued under the Loan Agreement (including the Holder) are referred to hereinafter as the “Holders”. The Holder is entitled to the benefits of the Loan Agreement, including, without limitation, the rights upon the occurrence and during the continuance of an Event of Default and the benefits of security interests and guaranties referred to below. Reference is made to the Loan Agreement and the documents entered into pursuant thereto with respect to certain additional rights of the Holder and obligations of the Company and its Subsidiaries not expressly set forth herein. Capitalized terms used herein but not otherwise defined herein shall have the meaning ascribed thereto in the Loan Agreement. Al
SECURED PROMISSORY NOTE ACURA PHARMACEUTICALS, INC.Acura Pharmaceuticals, Inc • June 23rd, 2005 • Pharmaceutical preparations • New York
This Note was issued by the Company pursuant to a certain Loan Agreement dated as of June 22, 2005 among the Company and certain lenders identified therein, including the Payee (together with the Schedules and Exhibits thereto, the “Loan Agreement”). The holders from time to time of the Notes issued under the Loan Agreement (including the Holder) are referred to hereinafter as the “Holders”. The Holder is entitled to the benefits of the Loan Agreement, including, without limitation, the rights upon the occurrence and during the continuance of an Event of Default and the benefits of security interests and guaranties referred to below. Reference is made to the Loan Agreement and the documents entered into pursuant thereto with respect to certain additional rights of the Holder and obligations of the Company and its Subsidiaries not expressly set forth herein. Capitalized terms used herein but not otherwise defined herein shall have the meaning ascribed thereto in the Loan Agreement. All
